Lv2
158 积分 2022-12-02 加入
Engineering of acidic pH-responsive anti-CD3 binding antibodies
2个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
3个月前
已完结
B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities
4个月前
已完结
De Novo Design of Peptide Masks Enables Rapid Generation of Conditionally-Active Miniprotein Binders
4个月前
已完结
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
4个月前
已完结
Hallmarks of cancer—Then and now, and beyond
5个月前
已完结
Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells
6个月前
已完结
Selectivity Approaches in Therapeutic Antibody Design
7个月前
已完结
Unveiling conformation-selective regulation of the norepinephrine transporter
7个月前
已完结
Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devices
8个月前
已完结
皖公网安备34019202002308
